Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

507
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
507
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

675
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
675
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

623
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
623
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

882
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
882

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Effect of Intensive Education in Patients With First-Ever Ischemic Stroke.

Journal of the American Heart Association·2026
Same author

Trends in Acute Care and Rehabilitation for First-Ever Stroke Patients: A 12-Year Perspective, the KOSCO Study.

Journal of Korean medical science·2026
Same author

Biosacetalin (1,1-Diethoxyethane) Improves Healthy Lifespan in <i>C. elegans</i> and Rats.

Antioxidants (Basel, Switzerland)·2026
Same author

Characteristics of children with disability through infant and children's health screening in South Korea.

Annals of medicine·2025
Same author

Dopaminergic Pathways in Neuroplasticity After Stroke and Vagus Nerve Stimulation.

Stroke·2025
Same author

The Significance of an Initial Controlling Nutritional Status Score in Predicting the Functional Outcome, Complications, and Mortality in a First-Ever Ischemic Stroke.

Nutrients·2024

Related Experiment Video

Updated: Jun 29, 2025

Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity
08:40

Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity

Published on: June 12, 2019

7.4K

Intrathecal Baclofen Injection Efficacy for Spasticity Management in Patients With Stroke: A Meta-Analysis.

Ki Deok Park1, Min-Keun Song2

  • 1Department of Rehabilitation Medicine, Gil Medical Center, Gachon University, Incheon, Korea.

Brain & Neurorehabilitation
|April 8, 2024
PubMed
Summary

Intrathecal baclofen injections effectively manage severe spasticity and improve gait speed in stroke patients unresponsive to traditional therapies. This therapy requires careful consideration of individual patient factors for optimal outcomes.

Keywords:
BaclofenIntrathecal InjectionMuscle SpasticityStroke

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.1K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.1K

Related Experiment Videos

Last Updated: Jun 29, 2025

Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity
08:40

Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity

Published on: June 12, 2019

7.4K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.1K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.1K

Area of Science:

  • Neurology
  • Rehabilitation Medicine
  • Pharmacology

Background:

  • Intrathecal baclofen injections are used for spasticity management in conditions like stroke, spinal cord injury, and CNS diseases.
  • The comparative efficacy of intrathecal baclofen injections for spasticity is debated.

Purpose of the Study:

  • To systematically review and meta-analyze the efficacy of intrathecal baclofen injections for spasticity and gait velocity in adult stroke patients.

Main Methods:

  • Systematic review of 3 databases (Cochrane Library, MEDLINE, Embase).
  • Inclusion of randomized controlled trials (RCTs) and non-randomized studies comparing intrathecal baclofen to other interventions.
  • Risk of Bias assessments using Cochrane's RoB tool and ROBINS-I.
  • Meta-analysis using Revman 5.4 and Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) for evidence validity.

Main Results:

  • The meta-analysis included 2 RCTs and 7 non-RCTs for spasticity, and 4 non-RCTs for gait velocity.
  • Intrathecal baclofen injection demonstrated a significant positive impact on spasticity reduction.
  • Significant improvements in gait velocity were observed with intrathecal baclofen injection.

Conclusions:

  • Intrathecal baclofen injection is a potential treatment for severe spasticity refractory to conventional therapies in stroke patients.
  • Individual patient characteristics and specific conditions should guide the decision-making process for intrathecal baclofen therapy.